Epstein Secrets

rld/middleeast/12syria-refugees-assad.html> (11/12, Hubbard, 18.61M) reports that "the Syrian government hosted a lavish conference in the capital, Damascus, this week aimed at trying to get the more than six million refugees who fled the country's civil war to come home," but "many refugees say they are

ters <https://www.reuters.corn/article/us-health-coronavirus-fatality/covid-19-fatality-rate-down-30-since- april-study-finds-idUSICBN27S39D> (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

eric who played a key role in government deals with rebel fighters, according to Syrian state media and a government website." The blast that killed Damascus Mufli Adnan Afiouni "took place in the town of Qudsaya, west of the capital of Damascus." It was not known who planted the bomb and no group immedia

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

es they were promised." The women "are often imprisoned in their employers' homes, and those who have escaped have fled to the Philippine Embassy in Damascus, where some of them say that about 35 women are now seeking shelter, unable to return home." THE BIG PICTURE Headlines From Today's Front Pages.

break from Trump's discursive approach to the pandemic as cases continue to climb nationwide." USA Today (1/24, Rivera, 12.7M) and Politico (1/24, Beasley, 6.73M) also report. US Passes 25M Confirmed Cases; Epidemiologist Pegs Total At More Than 105M. The AP (1/24) says "the new milestone" of 25 milli

der Current Leadership. The New York Times (11/12, Hubbard, 18.61t1) reports that "the Syrian government hosted a lavish conference in the capital, Damascus, this week aimed at trying to get the more than six million refugees who fled the country's civil war to come home," but "many refugees say they ar

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

ric who played a key role in government deals with rebel fighters, according to Syrian state media and a government website." The blast that killed Damascus Mufti Adnan Afiouni "took place in the town of Qudsaya, west of the capital of Damascus." It was not known who planted the bomb and no group immedi

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

nder Current Leadership. The New York Times (11/12, Hubbard, 18.61M) reports that "the Syrian government hosted a lavish conference in the capital, Damascus, this week aimed at trying to get the more than six million refugees who fled the country's civil war to come home," but "many refugees say they ar

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

ric who played a key role in government deals with rebel fighters, according to Syrian state media and a government website." The blast that killed Damascus Mufti Adnan Afiouni "took place in the town of Qudsaya, west of the capital of Damascus." It was not known who planted the bomb and no group immedi

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-